Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates

Infection and Immunity

Volumn 65, Issue 12, 1997, Pages 5209-5215

  Norrby Teglund, Anna ^a   Lustig, Robert ^b   Kotb, Malak ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CYTOKINE; EXOTOXIN; INTERLEUKIN 1BETA; STREPTOCOCCUS ANTIGEN; SUPERANTIGEN; VIRULENCE FACTOR;

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MITOGENESIS; NECROTIZING FASCIITIS; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; SUPERNATANT; TOXIC SHOCK SYNDROME;

EID: 0030785494     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.12.5209-5215.1997     Document Type: Article

References (45)

1. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793.
2. Andersson, J., S. Nagy, L. Björk, J. Abrams, S. Holm, and U. Andersson. 1992. Bacterial toxin-induced cytokine production studied at the single-cell level. Immunol. Rev. 127:09-96.
3. Bisno, A. L., and D. L. Stevens. 1996. Streptococcal infections of skin and soft tissues. N. Engl. J. Med. 334:240-245.
4. Bohach, G. A., D. J. Fast, R. D. Nelson, and P. M. Schlievert. 1990. Staphylococcal and Streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit. Rev. Microbiol. 17:251-272.
5. Cavaillon, J., C. Munoz, C. Fitting, B. Misset, and J. Carlet. 1992. Circulating cytokines: the tip of the iceberg? Circ. Shock 38:145-152.
6. Cerami, A. 1992. Inflammatory cytokines. Clin. Immunol. Immunopathol. 62:3-10.
7. Chizzolini, C., R. Chicheportiche, D. Burger, and J.-M. Dayer. 1997. Human Th1 cells preferentially induce interleukin (IL)-1β while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes. Eur. J. Immunol. 27:171-177.
8. Cleary, P. P., E. L. Kaplan, J. P. Handley, A. Wlazlo, M. H. Kim, A. R. Hauser, and P. M. Schlievert. 1992. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 339:518-521.
9. Del Prete, G. F., M. De Carli, C. Mastromauro, R. Biagotti, D. Macchia, P. Falagani, M. Ricci, and S. Romagnani. 1991. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88:346-350.
10. Demers, B., A.-E. Simor, H. Vellend, P. M. Schlievert, S. Byrne, F. Jamieson, S. Valmsley, and D. E. Low. 1993. Severe invasive group A Streptococcal infections in Ontario. Canada: 1987-1991. Clin. Infect. Dis. 16:792-800.
11. Dinarello, C. A. 1991. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J. Infect. Dis. 163:1177-1184.
12. Güler, M. L., J. D. Gorham, C.-S. Hsieh, A. J. Mackey, R. G. Steen, W. F. Dietrich, and K. M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 271:984-987.
13. Hackett, S. P., and D. L. Stevens. 1992. Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J. Infect. Dis. 165:879-885.
14. Holm, S. E., A. Norrby, A. M. Bergholm, and M. Norgren. 1992. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J. Infect. Dis. 166:31-37.
15. + cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.
16. Kline, J. B., and C. M. Collins. 1996. Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A. Infect. Immun. 64:861-869.
17. Kotb, M. 1995. Bacterial pyrogenic exotoxins as superantigens. Clin. Microbiol. Rev. 8:411-426.
18. Kotb, M. 1992. Role of superantigens in the pathogenesis of infectious diseases and their sequelae. Curr. Opin. Infect. Dis. 5:364-374.
19. Kotb, M., D. Newton, A. Norrby-Teglund, A. McGeer, and D. Low. 1996. Superantigenicity and Vβ-specificity of culture supernatants from streptococcal toxic shock syndrome isolates, abstr. B-345, p. 214. In Abstracts of the 96th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
20. Kotb, M., H. Ohnishi, G. Majumdar, S. Hackett, A. Bryant, G. Higgins, and D. Stevens. 1993. Temporal relationship of cytokine release by peripheral blood mononuclear cells stimulated by the Streptococcal superantigen pep M5. Infect. Immun. 61:1194-1201.
21. Kunkel, S. L., and D. G. Remick. 1992. Cytokines in health and disease. Marcel Dekker, New York, N.Y.
22. Le Gros, G., S. Z. Ben-Sasson, R. Seder, F. D. Finkelman, and W. E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:921-929.
23. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705-711.
24. Miethke, T., C. Wahl, D. Regele, H. Gaus, K. Heeg, and H. Wagner. 1993. Superantigen mediated shock: a cytokine release syndrome. Immunobiology 189:270-284.
25. Mollick, J. A., G. G. Miller, J. Musser, R. G. Cook, D. Grossman, and R. R. Rich. 1993. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J. Clin. Invest. 92:710-719.
26. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357.
27. Musser, J. M., A. R. Hauser, M. H. Kim, P. M. Schlievert, K. Nelson, and R. K. Selander. 1991. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. USA 88:2668-2672.
28. Norrby-Teglund, A., D. Newton, M. Kotb, S. E. Holm, and M. Norgren. 1994. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect. Immun. 62:5227-5233.
29. Norrby-Teglund, A., M. Norgren, S. E. Holm, U. Andersson, and J. Andersson. 1994. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect. Immun. 62:3731-3738.
30. Norrby-Teglund, A., K. Pauksens, S. E. Holm, and M. Norgren. 1994. Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J. Infect. Dis. 170:585-591.
31. 30a.Norrby-Teglund, A., et al. Unpublished data.
32. Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241-251.
33. Sander, B., J. Andersson, and U. Andersson, 1991. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol. Rev. 119:65-93.
34. Schlievert, P. M. 1993. Role of superantigens in human diseases. J. Infect. Dis. 167:997-1002.
35. Stevens, D. L. 1992. Invasive group A streptococcus infections. Clin. Infect. Dis. 14:2-13.
36. Stevens, D. L., M. H. Tanner, J. Winship, R. Swarts, K. M. Ries, P. M. Schlievert, and E. Kaplan. 1989. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321:1-7.
37. Street, N. E., J. H. Schumacher, T. A. Fong, H. Bass, D. F. Fiorentino, J. A. Leverah, and T. R. Mosmann. 1990. Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J. Immunol. 144:1629-1639.
38. Sullivan, G. W., and G. L. Mandell. 1991. The role of cytokines in infection. Curr. Opin. Infect. Dis. 4:344-349.
39. Swain, S. L., L. M. Bradley, M. Croft, S. Tonkonogy, G. Atkins, A. D. Weinberg, D. D. Duncan, S. M. Hedrick, R. W. Dutton, and G. Huston. 1991. Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol. Rev. 123:115-144.
40. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory function that bridges innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
41. Tyler, S. D., W. M. Johnson, J. C. Huang, F. E. Ashton, G. Wang, D. E. Low, and K. R. Rozee. 1992. Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991. J. Clin. Microbiol. 30:3127-3131.
42. Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Strieter, and S. L. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64:4733-4738.
43. Watanabe-Ohnishi, R., D. E. Low, A. McGeer, D. L. Stevens, P. M. Schlievert, D. Newton, B. Schwartz, B. Kreiswirth, the Ontario Streptococcal Study Project, and M. Kotb. 1995. Selective depletion of Vβ-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. J. Infect. Dis. 171:74-84.
44. Working Group on Severe Streptococcal Infections. 1993. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 269:390-391. (Comment.)
45. Yamamura, M., K. Uyemura, R. J. Deans, K. Weinberg, T. H. Rea, B. R. Bloom, and R. L. Modlin. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277-279.